Discriminative stimulus effects of BAY 38-7271, a novel cannabinoid receptor agonist
- 27 November 2002
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 457 (2-3) , 147-152
- https://doi.org/10.1016/s0014-2999(02)02697-3
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Behavioral pharmacology of cannabinoids in animalsEuropean Neuropsychopharmacology, 2002
- Characterization of the Diarylether Sulfonylester (−)-(R)-3-(2-Hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a Potent Cannabinoid Receptor Agonist with Neuroprotective PropertiesThe Journal of Pharmacology and Experimental Therapeutics, 2002
- SR141716A, a potent and selective antagonist of the brain cannabinoid receptorPublished by Wiley ,2001
- ( R )-Methanandamide and Δ 9 -THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamidePsychopharmacology, 2001
- Discriminative stimulus properties of the 5-HT1A receptor agonist BAY x 3702 in the rat.European Journal of Pharmacology, 1998
- Effects of the cannabinoid CB1 receptor antagonist SR141716A on the behavior of pigeons and ratsPsychopharmacology, 1996
- Pharmacological specificity of Δ9-tetrahydrocannabinol discrimination in ratsPsychopharmacology, 1995
- Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxicationNeuroscience & Biobehavioral Reviews, 1992
- Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogsPharmacology Biochemistry and Behavior, 1991
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964